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ABSTRACT
The effect of captopril on melanin formation in B16 cells was investigated. In B16 intracellular model system, the effect of captopril
on antityrosinase activity was found dose-dependent and correlated to its ability to suppress melanin formation. The copper chelation by
captopril may in part be responsible for the inhibition of tyrosinase activity. Captopril also displayed a remarkable reducing ability and
significantly inhibited ROS generation. Interestingly, captopril also significantly suppressed tyrosinase mRNA expression, as determined
by reverse transcription-polymerase chain reaction (RT-PCR). Overall, the results showed that the protective effect of captopril makes it a
potent inhibitor of melanin formation.
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INTRODUCTION
Melanins are natural pigments present in animal and
plant kingdoms. Many research have been published on the
melanin synthesis(1,2). Riley(2) noted that melanin has many
biological functions including antibiotic properties, strengthening element of plant cell walls, light absorption, and
scavenging free radical. However, Nofsinger and others(3)
reported there are also negative aspects of melanin, which
play a role in generating reactive oxygen species (ROS) and
in carcinogenesis. Skin exposed to ultraviolet light (UV)
produces ROS; these ROS’s promote melanin biosynthesis
and destroy deoxyribonucleic acid (DNA) and then induce
the proliferation and apoptosis of melanocytes(4,5). Previous
studies showed ROS scavengers and inhibitors of ROS
production such as antioxidants may reduce hyperpigmentation or prevent new UV-induced melanogenesis(4). Apart
from the properties mentioned above, localized hyperpigmentation is a sign of abnormal pigment cell function, such
as malignant melanoma(2), and overproduction of melanin
causes undesirable skin coloration(6). Melanin biosynthesis
is a result of a series of oxidative reactions involving tyrosine in the presence of the enzyme tyrosinase(7). Tyrosinase
catalyzes two distinct oxidative reactions: the hydroxylation
of tyrosine to L-3, 4-dihydroxyphenylalanine (L-DOPA) and
the oxidation of L-DOPA to dopaquinone(8). Quinones are
highly reactive compounds and thereby polymerize to form
* Author for correspondence. Tel: +886-6-2668618;
Fax: +886-6-2668618; E-mail: ipdduh@mail.chna.edu.tw

melanins(7). Many reports have shown melanin formation
may be prevented by avoiding ultraviolet exposure, by inhibiting tyrosinase, by inhibiting melanocyte metabolism and
proliferation, or by removing melanin by corneal ablation(7).
Among these, apart from avoiding ultraviolet exposure, using
tyrosinase inhibitors may be a simple and effective way to
prevent melanin formation(6). Therefore, the development
and searching for potential and effective tyrosinase inhibitors
have received much attention.
Captopril, an angiotensin converting enzyme inhibitor,
has long been used in treating congestive heart failure. In
addition, captopril with a sulfhydryl functional group has
been reported as a dietary thiol. Furthermore, captopril was
found to be present in vegetables such as asparagus(9,10).
Regarding the biological effects of thiols, more dietary thiol
supplements could regulate cell and tissue thiols in different
models. Cellular thiols redox status can modulate physiological metabolism, including its immune regulating and antiinflammatory properties, scavenging reactive oxygen species,
antioxidant properties, antitumor, antifibrotic and cytoprotective effects(11-14). As to melanin biosynthesis, captopril has
been demonstrated to inhibit tyrosinase activity because of
its binding the enzyme at its active site(15). However, the
mechanism of anti-tyrosinase activity of captopril is not yet
understood although captopril has been described as a tyrosinase inhibitor. Thus, the present study was aimed at exploring
the effect of captopril against melanin formation in B16 cells,
and the mechanism of action also evaluated.
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MATERIALS AND METHODS
I. Reagents
Captopril, 2’,7’-dichlorofluorescin diacetate (DCFHDA), synthetic melanin, dimethyl sulfoxide (DMSO), and
mushroom tyrosinase were purchased from Sigma-Aldrich
Co. (St. Louis, MO, USA). L-3,4-dihydroxyphenylalanin
(L-DOPA) was obtained from Acros Organic (Geel, Belgium).
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic
acid (Trolox) were purchased from E. Merck (Darmstadt,
Germany). Trizol reagent and RT-PCR kit were obtained
from Invitrogen (Carlsbad, CA, USA).
II. Determination of Reducing Activity
The reducing power of captopril was determined as
previously described(16). Captopril in phosphate buffer
(2.5 mL, 0.2 M, pH 6.6) was added to potassium ferricyanide
(2.5 mL, 10 mg/mL), and the mixture was incubated at 50°C
for 20 min. TCA (2.5 mL, 100 mg/mL) was added to the
mixture, which was then centrifuged at 650 g for 10 min. The
supernatant (2.5 mL) was mixed with distilled water (2.5 mL)
and ferric chloride (0.5 mL, 1.0 mg/mL), and then the absorbance was read at 700 nm. Higher absorbance of the reaction
mixture indicated greater reducing power.
III. Determination of Copper Chelating in Tyrosinase
Copper chelating in tyrosinase was determined as previously described(17) with slight modification. The mixture
consisting of 0.1 mL test compound (0.1 mM), 0.7 mL 10 mM
phosphate buffer (pH 6.8), and 0.2 mL mushroom tyrosinase
(250 U/mL), was incubated at 25°C for 30 min followed by
the UV-visible spectra (200-500 nm) acquisition.
IV. Cell Culture
B16 mouse melanoma cells were cultured in 9 mL
DMEM medium containing 1 mL heat-inactivated fetal
bovine serum, 2 mM L-glutamine, 100 U/mL penicillin
and 100 μg/mL streptomycin at 37°C in a humidified 5%
CO2/95% air controlled incubator(18).
V. Cell Viability Assay
The MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-dephenyltetrazolium bromide) assay was performed as previously
described(19). MTT is a tetrazolium salt and can be converted
to insoluble formazan by mitochondrial dehydrogenase in
living cells. Briefly, cells were dispensed into 96-well plates
and captopril was added and cultured for 24 h. Then, 20 μL
MTT (5 mg/mL stock solution) were added to each well. After
1 h, the reaction was terminated and the plates were incubated for 30 min to solubilize the formazan dye by addition
of DMSO. The optical density of each well was measured on
an Anthos 2010 microplate reader at 570 nm.

VI. Evaluation of ROS in B16 Cells
To assess the generation of ROS in B16 cells, DCFH-DA
was introduced to penetrate the cell membranes and hydrolyzed by intracellular esterase to form dichlorofluorescin
(DCFH)(18). Subsequently, DCFH reacted with ROS generated by intracellular stress to produce highly fluorescent DCF
which emitted fluorescence when excited at 485 nm. Various
concentrations of captopril in DMSO were incubated at 25°C
for 30 min in the presence of DCFH-DA (50 μM). After incubation, ROS generation was detected on a Bio-Tek FLx800
microplate fluorescence reader with excitation and emission
wavelengths of 485 and 530 nm, respectively. Inhibition
(%) = (1 – B / A) × 100%; A: value of fluorescence without
sample, and B: value of fluorescence with sample.
VII. Assay of Inhibitory Tyrosinase Activity
The anti-tyrosinase activity was determined as the degree
of inhibition on tyrosinase-catalyzed oxidation of L-DOPA
as previously described(18). After B16 cells were cultured
with or without captopril (0-400 μg/mL) for 24 h, they were
washed with ice-cold PBS, and then treated with 1 mL lysis
buffer [PBS containing 1% Nonidet P-40, 1% SDS and 0.2%
proteinase inhibitor cocktail (Roche Diagnostics GmbH,
Mannheim, Germany)]. Cellular lysates were centrifuged at
10,000 g at 4°C for 20 min. The supernatants were collected
and the protein contents were determined using the BCA
protein assay kit (Thermo Scientific, Rockford, IL, USA) and
the remaining was stored at -80°C for the subsequent assays
of anti-tyrosinase activities. The reaction mixture consisted
cell extract supernatant (0.1 mL), 25 mM phosphate buffer
(0.8 mL, pH 6.8), and L-DOPA (3.8 mM) was added in to
read the absorbance at 475 nm for 30 min. The reaction was
performed at 25°C. The value in the absence of captopril was
used as the control.
Inhibition (%) = [1 − (OD475 in sample / OD475 in
control)] × 100%
VIII. Melanin Assay
Melanin assay was performed using procedures
described previously(18) with slight modifications. Test
samples were added to the cell and cultured for 24 h. After
washing two times in PBS, cells were harvested by short
incubation with trypsin-EDTA. An aliquot was used for cell
counting and the remaining cells were centrifuged at 10,000
g for 15 min. The cells were lysed in 500 μL of 5 N NaOH
at 100°C for 1 h, and 200 μL portions of crude cell extract
were transferred to 96-well plates. Melanin concentrations
were calculated by comparison of the absorbance at 405 nm
of unknown samples with a standard curve obtained using
synthetic melanin (0-200 μg/mL).
IX. Reverse Transcriptase-Polymerase Chain Reaction
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Total RNA was isolated from cells by using Trizol
reagent (Invitrogen, California, USA) according to the
manufacturer’s instructions. Then, RNA concentrations
were determined spectrophotometrically and 1 μg RNA was
converted to the first strand cDNA and amplification of target
cDNA using an Invitrogen SuperScript TM III First-strand
synthesis system. The same amount of the resulting cDNA
was then used for amplification using the following primers:
tyrosinase forward 5′-GGCCAGCTTTCAGGCAGAGGT;
and downstream 5′-TGGTGCTTCATGGGCAAAATC. The
cDNA sequence of GAPDH was also amplified as control
in a similar way using primer pair 5′-TGAAGGTCGGTGTGAACGGATTTGGC-3′ and 5′-CATGTAGGCCATGAGGTCCACCAC-3′. A thermal cycle of 60 sec at 94°C, 60 sec
at 56°C and 60 sec at 72°C was carried for 25 cycles. PCR
products were analyzed on 1.2% agarose gels and amplified
cDNA bands were detected by ethidium bromide staining(20).
X. Statistical Analysis
All data were recorded as means ± SD. Statistical
analysis involved the use of the Statistical Analysis System
software package. Analysis of variance was performed by
ANOVA procedures. Significant differences between means
were determined by Duncan’s multiple range tests at a level
of p < 0.05.

RESULTS AND DISCUSSION
Previous studies showed p-coumaric acid not only was a
natural dietary antioxidant playing an important role against
oxidative damage in corn bran(21), but also a strong tyrosinase inhibitor displaying competitive inhibition to eggplant
tyrosinase(22). It could be an antimelanogenesis agent in B16
cells(23). According to the facts mentioned above, p-coumaric
acid was used as a reference compound in this study.
I. Effect of Captopril on Cell Viability in B16 Cells
To examine the biological action of captopril in cellular
system, B16 cells were used as an in vitro model. Before in
vitro studies were performed, the effect of captopril on cell
viability was determined. As assayed with MTT method, cell
viability of the B16 cells treated with captopril in the range of
0-400 μg/mL was > 95% (Table 1), indicating that captopril
exerted no cytotoxicity to B16 cells.
II. Effect of Captopril on ROS Generation in B16 Cells
Under physiological metabolism, the excessive level of
ROS could decrease the intracellular antioxidant capacity and
thus produce oxidative stress. In addition, ROS may induce
and enhance the development of melanin formation(18).
Therefore, removing ROS may contribute to the inhibition
of melanin formation. Thus, in the present investigation, the
intracellular level of ROS was measured using a fluorescent

probe DCFH-DA by fluorospectrometry. As shown in Table
2, the fluorescence intensity decreased as compared to control
when captopril was added to B16 cells, indicating the inhibition of ROS generation by the treatment of captopril. Wang
et al.(6) noted the antioxidants may prevent or delay pigmentation via various routes, including by scavenging ROS and
RNS (reactive nitrogen species), or by reducing o-quinones
or other intermediates in melanin biosynthesis, consequently,
which in turn slows down the pigmentation. Without thiocontaining compounds, dopaquinone spontaneously converts
initially to dopochrome and then to indole-5, 6-quinone or
indole-5, 6-quinone 2-carboxylic acid. After multi-biosynthesis steps, further polymerization yields melanin(8). In addition, 5,6-dihydroxyindole and 5,6-dihydroxyindole-2-carboxylic acid, which are melanin precursors in melanogenesis,
can be converted into the corresponding melanin pigments
by the action of lipoxygenase/H2O2 system or due to the
generation of ROS, revealing ROS generation may heighten
melanin formation(24). These observations imply a strong
relationship between ROS generation and melanin formation.
In other words, the suppression of ROS by captopril is in part
a contributor to the inhibition of melanin formation.
III. Effect of Captopril on Reducing Activity
Figure 1 showed the reducing ability of captopril. The
reducing ability of captopril increased with the concentration of captopril. The equation of reducing ability (Y) and
concentration of captopril (X) used is Y = 0.096 X + 0.00384
(r2 = 0.972, p < 0.05), indicating the reducing ability correlated well with concentration of captopril. At a concentration
of 100 μg/mL, the reducing ability of captopril was inferior
to that of ascorbic acid which is a strong reducing agent,
but superior to that of p-coumaric acid. Reducing ability is
related to a reducing agent that contributes to the breaking of
Table 1. Effect of captopril on B16 melanoma cell viability for 48 h
Concentration (μg/mL)

Cell viability (% of control)

100

102.2 ± 1.8a

200

98.8 ± 3.4a

400

101.7 ± 4.2a

Data are presented by means ± SD (n = 3). Values with the same
superscripts (a) in each column are not significantly different (p <
0.05).
Table 2. The effect of captopril on ROS formation in B16 cells by
using the DCFH-DA fluorescence probe
Compound

Concentration
(μg/mL)

Inhibition of ROS generation
(% of control)

Captopril

100

17.1 ± 2.3a

200

37.4 ± 2.0b

400
42.5 ± 3.2b
The data were displayed with mean ± SD for (n = 3). Mean values
with different superscripts (a,b) in each column are significantly
different (p < 0.05).

671
Journal of Food and Drug Analysis, Vol. 20, No. 3, 2012

a radical chain by donating a hydrogen atom(25). Moridani(26)
noted that ascorbic acid prevented the o-quinone formation
when 4-hydroxyanisole was metabolized by tyrosinase/O2.
In addition, SH-containing compounds are effective inhibitors of pigment formation(27). In the current study, captopril
exerted significant reducing action (Figure 1) and thereby
reduced the product dopaquinone back to L-DOPA. Thus,
the reducing ability may partly contribute to inhibit melanin
formation by donating a hydrogen atom from the SH group
in captopril.
IV. Effect of Captopril on Tyrosinase and Melanin in B16
Cells
Table 3 shows the effect of captopril on tyrosinase
activity and melanin content of B16 cell. The inhibition of
tyrosinase activity increased with the increasing concentration of captopril. Also, the inhibitory action on melanin
formation by captopril occurred in a concentration dependent manner. Apparently, inhibition of melanin synthesis
was related to the level of tyrosinase inhibition. Melanin is
synthesized by a multi-step pathway, and apart from tyrosinase, synthesis is also controlled by other enzymes such as

5,6-dihydroxyindole-2-carboxylic acid oxidase and dopachrome tautomerase(28). However, tyrosinase plays a crucial
role in melanin biosynthesis and accounts for melanization
in animals and browning in plants(29). Therefore, the inhibition of tyrosinase activity by captopril may contribute to the
reduction of melanin formation.
V. Effect of Captopril on Copper Chelating
Tyrosinase contains a strongly coupled binuclear copper
active site and functions both as a monophenolase and as an
o-diphenolase(30). Therefore, copper chelation may contribute
to the inhibition of tyrosinase activity. To see whether captopril can chelate copper in the enzyme, the captopril was let to
react with tyrosinase and the wavelength shift was monitored
for this aim(17). Based on the data gained from Figure 2, the
absorption maximum of captopril (in profile a) shifted to
short wavelength after it reacted with tyrosinase (profile b).
This observation agreed with the report of Kubo and KinstHori(17) who noted that kaempferol made the noticeable shift
to a short wavelength as it chelated copper in the tyrosinase.
This finding suggested captopril be a copper chelator(15,17),
and this copper chelation mechanism may account for its
inhibition of tyrosinase activity.
1641-101.05.09-revised

Table 3. The effects of captopril on tyrosinase activity and melanin
formation in B16 cells

1.0

Captopril concentration
(μg/mL)

Tyrosinase activity
inhibition(%)

Melanin formation
inhibition(%)

1.0

100

22.5 ± 2.8a

15.1 ± 2.9a

0.8

200

b

a

b

400
35.1 ± 2.5
26.5 ± 2.1
The data were displayed with mean ± SD for n = 3. Values with
different superscripts (a,b,c) in a column are significantly different (p
< 0.05).
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Figure 3. Effect of captopril on tyrosinase mRNA production in B16
absorbance of the reaction mixture indicated greater reducing power.
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described in Methods.
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VI. Effect of Captopril on mRNA Level of Tyrosinase in B16
Cells
To further explain a possible mechanism responsible for
the lack of tyrosinase activity in B16 cells, the transcription of
tyrosinase gene was further clarified. Thus, the expressions of
tyrosinase mRNA were examined by RT-PCR analysis. The
effects of captopril on the expression of tyrosinase mRNA in
B16 cells is shown in Figure 3. The gene for GAPDH served
as the housekeeping gene. The levels of mRNA encoding
tyrosinase were found to be down-regulated by captopril at
the concentration range of 100 to 400 μg/mL. Apparently, the
presence of captopril in B16 cells suppressed the expression
of tyrosinase mRNA. This observation may also be responsible for the antityrosinase activity and reduction of melanin
in B16 cells.
In summary, captopril inhibited tyrosinase activity
thereby reducing the melanin biosynthesis. This effect may be
chiefly because of its reducing ability, chelating copper and
the inhibition of tyrosinase expression. In addition, inhibition
of ROS formation by captopril may be one of the contributors
to the reduction of melanin formation.
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